Insights from 2024 ASCO® GU Annual Meeting


 

ASCO® GU 2024 Insights: "Nivo + Cabozantinib vs. Sunitinib for Previously Untreated Advanced RCC - Results From 55-Month Follow-Up of the CheckMate 9ER Trial"

252 views
February 20, 2024
Comments 0
Login to view comments. Click here to Login